The financial barrier stopping new antibiotics
Clip: 08/03/2017 | 8m 46s
As current antibiotics begin to lose their punch, there’s an economic reality putting a damper on development. Since every use of an antibiotic drives resistance, and doctors are reluctant to use a drug until there's no alternative, why would a drug company spend a fortune? Economics correspondent Paul Solman and science correspondent Miles O’Brien continue their look at the hunt for new drugs.
Aired: 08/03/17Video has closed captioning.
Problems Playing Video?
Major corporate funding for the PBS NewsHour is provided by BNSF, Consumer Cellular, Leidos, Babbel, and Raymond James. Funding for the PBS NewsHour Weekend is provided by Mutual of America. For a complete list of funders for the PBS NewsHour and PBS NewsHour weekend, click here.